PURPOSE: Histone lysine methylation (HKM) is an important epigenetic mechanism that establishes cell-specific gene expression and functions in development. However, epigenetic control of retinal development is poorly understood. To study the roles of HKM in retinogenesis, the authors examined the dynamic changes of three HKM modifications and of two of their regulators, the histone methyltransferases (HMTases) Ezh2 and G9a, in the mouse retina. METHODS: Retinal sections and lysates from embryonic day 16 through adult were processed for immunohistochemistry and immunoblotting using antibodies against various marks and HMTases. To further analyze the biological functions of HKM, the effects of small molecule inhibitors of HMTases were examined in vitro. RESULTS: Methylation marks of trimethyl lysine 4 and 27 on histone H3 (H3K4me3 and H3K27me3) were detected primarily in differentiated retinal neurons in the embryonic and adult retina. In contrast, dimethyl lysine 9 on histone H3 (H3K9me2) was noted in early differentiating retinal ganglion cells but was lost after birth. The HMTases controlling H3K27me3, H3K9me2, Ezh2, and G9a were enriched in the inner embryonic retina during the period of active retinogenesis. Using the chemical inhibitors of Ezh2 and G9a, the authors reveal a role for HKM in regulating retinal neuron survival. CONCLUSIONS: HKM is a dynamic and spatiotemporally regulated process in the developing retina. Epigenetic regulation of gene transcription by Ezh2- and G9a-mediated HKM plays crucial roles in retinal neuron survival and may represent novel epigenetic targets to enhance viability in retinal neurodegenerative diseases such as glaucoma.
PURPOSE: Histone lysine methylation (HKM) is an important epigenetic mechanism that establishes cell-specific gene expression and functions in development. However, epigenetic control of retinal development is poorly understood. To study the roles of HKM in retinogenesis, the authors examined the dynamic changes of three HKM modifications and of two of their regulators, the histone methyltransferases (HMTases) Ezh2 and G9a, in the mouse retina. METHODS: Retinal sections and lysates from embryonic day 16 through adult were processed for immunohistochemistry and immunoblotting using antibodies against various marks and HMTases. To further analyze the biological functions of HKM, the effects of small molecule inhibitors of HMTases were examined in vitro. RESULTS: Methylation marks of trimethyl lysine 4 and 27 on histone H3 (H3K4me3 and H3K27me3) were detected primarily in differentiated retinal neurons in the embryonic and adult retina. In contrast, dimethyl lysine 9 on histone H3 (H3K9me2) was noted in early differentiating retinal ganglion cells but was lost after birth. The HMTases controlling H3K27me3, H3K9me2, Ezh2, and G9a were enriched in the inner embryonic retina during the period of active retinogenesis. Using the chemical inhibitors of Ezh2 and G9a, the authors reveal a role for HKM in regulating retinal neuron survival. CONCLUSIONS: HKM is a dynamic and spatiotemporally regulated process in the developing retina. Epigenetic regulation of gene transcription by Ezh2- and G9a-mediated HKM plays crucial roles in retinal neuron survival and may represent novel epigenetic targets to enhance viability in retinal neurodegenerative diseases such as glaucoma.
Authors: Karl Agger; Paul A C Cloos; Jesper Christensen; Diego Pasini; Simon Rose; Juri Rappsilber; Irina Issaeva; Eli Canaani; Anna Elisabetta Salcini; Kristian Helin Journal: Nature Date: 2007-08-22 Impact factor: 49.962
Authors: Bruno Perillo; Maria Neve Ombra; Alessandra Bertoni; Concetta Cuozzo; Silvana Sacchetti; Annarita Sasso; Lorenzo Chiariotti; Antonio Malorni; Ciro Abbondanza; Enrico V Avvedimento Journal: Science Date: 2008-01-11 Impact factor: 47.728
Authors: Fei Lan; Peter E Bayliss; John L Rinn; Johnathan R Whetstine; Jordon K Wang; Shuzhen Chen; Shigeki Iwase; Roman Alpatov; Irina Issaeva; Eli Canaani; Thomas M Roberts; Howard Y Chang; Yang Shi Journal: Nature Date: 2007-09-12 Impact factor: 49.962
Authors: Kathrin Plath; Jia Fang; Susanna K Mlynarczyk-Evans; Ru Cao; Kathleen A Worringer; Hengbin Wang; Cecile C de la Cruz; Arie P Otte; Barbara Panning; Yi Zhang Journal: Science Date: 2003-03-20 Impact factor: 47.728
Authors: Jeongwu Lee; Myung Jin Son; Kevin Woolard; Nicholas M Donin; Aiguo Li; Chui H Cheng; Svetlana Kotliarova; Yuri Kotliarov; Jennifer Walling; Susie Ahn; Misuk Kim; Mariam Totonchy; Thomas Cusack; Chibawanye Ene; Hilary Ma; Qin Su; Jean Claude Zenklusen; Wei Zhang; Dragan Maric; Howard A Fine Journal: Cancer Cell Date: 2008-01 Impact factor: 31.743
Authors: Tjadine M Holling; Marloes W T Bergevoet; Louis Wilson; Marja C J A Van Eggermond; Erik Schooten; Renske D M Steenbergen; Peter J F Snijders; Martine J Jager; Peter J Van den Elsen Journal: J Immunol Date: 2007-10-15 Impact factor: 5.422
Authors: Tarjei S Mikkelsen; Manching Ku; David B Jaffe; Biju Issac; Erez Lieberman; Georgia Giannoukos; Pablo Alvarez; William Brockman; Tae-Kyung Kim; Richard P Koche; William Lee; Eric Mendenhall; Aisling O'Donovan; Aviva Presser; Carsten Russ; Xiaohui Xie; Alexander Meissner; Marius Wernig; Rudolf Jaenisch; Chad Nusbaum; Eric S Lander; Bradley E Bernstein Journal: Nature Date: 2007-07-01 Impact factor: 49.962
Authors: Anja Eberhart; Yana Feodorova; Congdi Song; Gerhard Wanner; Elena Kiseleva; Takahisa Furukawa; Hiroshi Kimura; Gunnar Schotta; Heinrich Leonhardt; Boris Joffe; Irina Solovei Journal: Chromosome Res Date: 2013-08-31 Impact factor: 5.239
Authors: Shivakumar Subbanna; Madhu Shivakumar; Nagavedi S Umapathy; Mariko Saito; Panaiyur S Mohan; Asok Kumar; Ralph A Nixon; Alexander D Verin; Delphine Psychoyos; Balapal S Basavarajappa Journal: Neurobiol Dis Date: 2013-02-08 Impact factor: 5.996
Authors: Louise F Porter; Giorgio G Galli; Sally Williamson; Julian Selley; David Knight; Nursel Elcioglu; Ali Aydin; Mustafa Elcioglu; Hanka Venselaar; Anders H Lund; Richard Bonshek; Graeme C Black; Forbes D Manson Journal: Hum Mol Genet Date: 2015-09-22 Impact factor: 6.150